Vitrivax
$29.4M
Funding date
Valuation / Funding
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| November 17, 2025 | Later Stage VC (Series B) | $29.4M | N/A | - |
Current Valuation Metrics
Vitrivax is currently valued at $69.4M as of November 17, 2025. The company has raised a total of $38.2M in funding across 1 funding round.
Capital Efficiency
With a capital efficiency ratio of 1.82x, Vitrivax has achieved a valuation that is 1.82 times the total capital raised.
What is Vitrivax Worth in 2026?
Vitrivax is a leading private company in the Discovery Tools (Healthcare) sector. Track Vitrivax's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Vitrivax Valuation is Determined
Private company valuations like Vitrivax's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.